HCPLive Network

CDC Addresses Burden, Threat of Antibiotic Resistance

MONDAY, Jan. 6, 2014 (HealthDay News) -- The burden and threats posed by antibiotic resistance infections are discussed in a report published by the U.S. Centers for Disease Control and Prevention.

Noting that antibiotic resistance is a worldwide problem, researchers from the CDC discuss the burden and threat of antibiotic resistance to bacteria that can cause severe human infections.

The researchers note that antibiotic resistance causes an estimated minimum of two million illnesses and 23,000 deaths per year, and one of the most urgent threats is Clostridium difficile, which causes an estimated minimum of 250,000 illnesses and 14,000 deaths per year. The estimated costs of antibiotic resistance could be as high as $20 billion in direct costs and $35 billion in indirect costs such as lost productivity. Antibiotic use is the most important factor leading to antibiotic resistance, with up to 50 percent of antibiotics prescribed inappropriately. The spread of resistant strains from person to person or from non-human sources is also a major factor in antibiotic resistance. The four core actions to combat antibiotic-resistant infection are prevention of infections and of the spread of resistance; tracing resistant bacteria; improving antibiotic use; and promoting the development of new antibiotics.

"When first-line and then second-line antibiotic treatment options are limited by resistance or are unavailable, health care providers are forced to use antibiotics that may be more toxic to the patient and frequently more expensive and less effective," CDC Director Tom Frieden, M.D., M.P.H., said in a statement.

More Information


Copyright © 2014 HealthDay. All rights reserved.



Further Reading
While millions of Americans still feel hamstrung by medical expenses, a new government report shows that some people are getting relief.
Many Americans are paying less for prescription drugs, but some are having to deal with sharp rises in the cost of specialty medicines for rare or serious diseases, according to a new report.
Physicians who mainly engage in patient care contribute a total of $1.6 trillion in economic output, according to the American Medical Association's Economic Impact Study.
Price transparency frameworks, which provide price information presented in the context of other relevant information, should be developed to meet patients' needs, according to recommendations presented in a report from the Healthcare Financial Management Association.
There will be no more delays to the Oct. 1, 2014, deadline for implementation of the International Classification of Diseases, 10th Revision, according to an article published Feb. 27 in Medical Economics.
A reliable set of emotion words have been identified that can serve as a tool for experience-based design questionnaires in health care, according to a study published in the December issue of Healthcare.
The rationale behind the decision making processes of the U.S. Food and Drug Administration is discussed in three articles published in the Jan. 22/29 issue of the Journal of the American Medical Association.
More Reading